Aspire Private Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,500
Closed -$55.7K 564
2024
Q3
$55.7K Hold
1,500
0.01% 226
2024
Q2
$71.4K Hold
1,500
0.02% 214
2024
Q1
$57.4K Hold
1,500
0.02% 225
2023
Q4
$46.8K Hold
1,500
0.01% 228
2023
Q3
$60.3K Hold
1,500
0.02% 202
2023
Q2
$78.9K Hold
1,500
0.03% 174
2023
Q1
$95.9K Hold
1,500
0.03% 155
2022
Q4
$72.8K Hold
1,500
0.03% 163
2022
Q3
$106K Hold
1,500
0.04% 149
2022
Q2
$106K Hold
1,500
0.04% 151
2022
Q1
$120K Hold
1,500
0.04% 153
2021
Q4
$137K Hold
1,500
0.04% 155
2021
Q3
$193K Hold
1,500
0.06% 138
2021
Q2
$229K Hold
1,500
0.07% 135
2021
Q1
$158K Hold
1,500
0.06% 158
2020
Q4
$119K Hold
1,500
0.05% 165
2020
Q3
$85K Buy
+1,500
New +$80.8K 0.03% 181
2020
Q1
Sell
-1,500
Closed -$53K 447
2019
Q4
$53K Hold
1,500
0.02% 195
2019
Q3
$39K Hold
1,500
0.02% 197
2019
Q2
$44K Hold
1,500
0.02% 204
2019
Q1
$51K Buy
+1,500
New +$53.1K 0.03% 230

Other funds holding STAA

Aspire Private Capital's STAA Position: Q4 2024 in Review

Aspire Private Capital sold out of STAAR Surgical (STAA) in Q4 2024, closing a stake of 1,500 shares — an estimated $55.7K sold.

Aspire Private Capital first reported a position in STAA in Q1 2019 and held it in 21 quarters. The position peaked at $229K in Q2 2021. 212 funds tracked by Wall St. Rank hold STAA as of Q4 2024.

  • Aspire Private Capital reported no remaining STAAR Surgical position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 1,500 STAAR Surgical shares in Q4 2024, an estimated $55.7K.
  • Aspire Private Capital first reported a position in STAAR Surgical in Q1 2019 and held it in 21 quarters.
  • Aspire Private Capital's STAAR Surgical position peaked at $229K in Q2 2021.
  • 212 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.